Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence

Background A subset of metachronous colon cancer recurrence manifests as peritoneal metastases (PM). Risk factors for metachronous PM recurrence are not well‐defined in patients with stage II or III colon cancers after curative resection and standard adjuvant treatments. Methods Population data from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2021-02, Vol.123 (2), p.622-629
Main Authors: Le, Viet H., Thornblade, Lucas, Ituarte, Phillip H. G., Lai, Lily L., Melstrom, Kurt A.
Format: Article
Language:English
Subjects:
Aged
Colectomy - adverse effects
colectomy isolated peritoneal recurrence
colon cancer metachronous recurrence
colon cancer metastases
colon cancer peritoneal metastases
Colonic Neoplasms - pathology
Colonic Neoplasms - surgery
Colorectal cancer
Colorectal surgery
Female
Follow-Up Studies
Gastric cancer
Humans
Male
Metastasis
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Neoplasms, Second Primary - epidemiology
Neoplasms, Second Primary - secondary
peritoneal carcinomatosis colon resection
Peritoneal Neoplasms - epidemiology
Peritoneal Neoplasms - secondary
Retrospective Studies
Risk Factors
Surgical outcomes
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background A subset of metachronous colon cancer recurrence manifests as peritoneal metastases (PM). Risk factors for metachronous PM recurrence are not well‐defined in patients with stage II or III colon cancers after curative resection and standard adjuvant treatments. Methods Population data from the California Cancer Registry for patients with Stage II or III colon cancer were collected between 2004 and 2012. Multivariate analysis was used to identify factors associated with metachronous PM. Results Of the 2077 patients with stage II or III colon cancer, female patients (odds ratio [OR] = 1.84, p = 0.02), T4 primary tumor (OR = 2.36, p = 0.02), mucinous (OR = 3.97, p 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.26322